Nigeria Centre for Disease Control
© Credits

Mpox

    Overview

    Mpox (previously known as monkeypox) is a viral disease caused by an orthopoxvirus called monkeypox virus. It spreads mainly through close contact with someone who has mpox, causing a painful rash, enlarged lymph nodes and fever. It can make people very sick and leave scars.

    The disease mainly spreads from person to person through close contact. This includes, but isn’t limited to, sexual contact. Transmission occurs through exposure to bodily fluids; lesions on the skin or on internal mucosal surfaces, such as in the mouth or throat; respiratory particles; and contaminated objects. 

    In areas where animals carry the virus, mpox is a zoonotic disease, meaning it can spread from animals to humans. It's found in tropical rainforests in central, east and west Africa, where small mammals such as squirrels, Gambian pouched rats, dormice, and various species of monkeys may be carriers.

    Since May 2022, mpox has spread globally, with cases reported from countries without previously documented mpox transmission. The spread in most countries today is from people and not animals.

    Symptoms

    Mpox typically causes a fever, a rash resembling pimples or blisters and swollen lymph nodes.   Symptoms usually appear within a week of exposure but can take anywhere from 1 to 21 days to develop.

    The illness often begins with a feverish phase lasting 1 to 3 days with symptoms including intense headache, swollen lymph nodes back pain, muscle aches and severe fatigue. The first stage is followed by the skin eruption stage, lasting from 2 to 4 weeks. Lesions evolve from macules (lesions with a flat base) to papules (raised firm painful lesions) to vesicles (filled with clear fluid) to pustules (filled with pus), followed by scabs or crusts.  They can leave scars. For some people, the first symptom of mpox is the rash.

    Some people with mpox become very sick and it can even be fatal in some cases. Children, pregnant people and people with weak immune systems, including people living with HIV that is not well controlled, are at higher risk for serious illness and death due to complications from mpox.

    Prevention and treatment

    Prevention and control of mpox rely on raising awareness in communities and educating health workers to prevent infection and stop transmission.

    Mpox vaccines also provide protection against infection and severe disease. WHO recommends the use of vaccines for those most at risk of exposure during outbreaks, including people who have had close contact with someone with mpox, and health workers. People who were vaccinated against smallpox in childhood may have some cross-protection against mpox. 

    To prevent spread, close contact with people who have mpox or with contaminated materials should be avoided. Masks, gloves and other personal protective equipment should be worn while taking care of the sick, whether in a health facility or at home. 

    Where animal-to-human transmission is possible, contact with sick or dead animals should be avoided, and all foods containing animal meat or parts must be properly cooked before consumption. 

    Care of patients with mpox should focus on managing symptoms to make people feel better, and to prevent medical complications. Potential treatments against mpox are being developed and tested.

    News

    All →

    Latest publications

    All →
    Considerations for border health and points of entry for mpox: interim guidance

    On 14 August 2024, the Director-General of the World Health Organization determined that the upsurge of mpox in a growing number of countries in Africa...

    Cover for publication: Infection prevention  and control and water,  sanitation and hygiene  measures for home care  and isolation for mpox in  resource-limited settings

    This interim operational guide outlines infection prevention, control, and water, sanitation, and hygiene measures for home care and isolation of mpox...

    Gatherings in the context of the 2024 mpox outbreak: public health guidance

    This document examines the risk-based approach to gatherings, mpox-associated risks during the current public health emergency of international concern,...

    Smallpox and mpox 
(orthopoxviruses): WHO position paper, August 2024

    This position paper is concerned with vaccines and vaccination against mpox and smallpox. Since the publication of the 2014 meeting report on smallpox...

    WHO documents

    All →
    Mpox Sitrep #42 Thumbnail

    This is the 42nd situation report for the multi-country outbreak of mpox, which provides an update on the epidemiological situation of mpox in Africa (including...

    Mpox Situation Report #41 Thumbnail

    This is the 41st situation report for the multi-country outbreak of mpox, which provides details on the latest epidemiological trends, including an the...

    The mpox screening form for health facility entrances is a tool designed to enable early recognition of suspected mpox cases and rapid implementation...

    WHO Target Product Profiles for mpox Vaccines

    This document describes the preferred and minimally acceptable profiles for human vaccines for all clades of mpox.  All vaccines considered for use...